Innoviva (INVA) EPS (Diluted) Growth (3y) (2013 - 2026)
Innoviva (INVA) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.01% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.90% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 61.64% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 36.83% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.99% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -36.81% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 36.39% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 67.51% |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | -291.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -291.77% |
| Mar 31, 2026 | 78.25% |
| Dec 31, 2025 | -6.49% |
| Sep 30, 2025 | -24.66% |
| Jun 30, 2025 | 325.10% |
| Mar 31, 2025 | -85.81% |
| Dec 31, 2024 | -77.72% |
| Sep 30, 2024 | -74.95% |
| Jun 30, 2024 | -37.99% |
| Mar 31, 2024 | -19.50% |
| Dec 31, 2023 | -30.97% |
| Sep 30, 2023 | 76.74% |
| Jun 30, 2023 | -69.32% |
| Mar 31, 2023 | -12.34% |
| Dec 31, 2022 | -34.11% |
| Sep 30, 2022 | 103.20% |
| Jun 30, 2022 | -69.10% |
| Mar 31, 2022 | -17.35% |
| Dec 31, 2021 | -30.15% |
| Sep 30, 2021 | 96.00% |